Dues are based on the member company’s global analytical, life science, and diagnostics business revenues for the most recent business year. Companies that are the U.S. or North American division of an overseas corporation pay dues based on their North American business revenues.

“Diagnostics” business refers to revenues from: molecular diagnostics; companion diagnostics; and emerging and next generation diagnostic technologies such as cellular diagnostics. It does not include classical clinical and immumo in vitro diagnostics.

Annual Revenues (in US Dollars) Annual Dues

Under $10 million

$2,625

$10-15 million

$4,725

$15-25 million

$6,825

$25-50 million

$10,500

$50-100 million

$15,750

$100-200 million

$21,000

$200-300 million

$26,250

$300-750 million

$31,500

Over $750 million

$33,000

Associate Member

$5,500